Drugs / CB-0406
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04467684 | Jul 2020 → May 2021 | — | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CB-0406 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04467684 ↗ |
| Route | Oral | “blinded oral dose of CB-0406” NCT04467684 ↗ |